Skip to Content

A891 40 mg (Methylphenidate Hydrochloride Extended-Release 40 mg)

Pill with imprint A891 40 mg is Yellow & White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 40 mg. It is supplied by Actavis Pharma, Inc..

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for A891 40 mg

Methylphenidate hydrochloride extended-release 40 mg A891 40 mg

Methylphenidate Hydrochloride Extended-Release

Imprint
A891 40 mg
Strength
40 mg
Color
Yellow & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cns stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-3891

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.